Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01FUC
|
||||
Former ID |
DIB014573
|
||||
Drug Name |
Exatecan
|
||||
Synonyms |
Exatecan mesylate; DX-8951; DX-8951a; DX-8951f; UM-1; UM-2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 3 | [521494] | ||
Company |
Daiichi Seiyaku Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H22FN3O4
|
||||
Canonical SMILES |
n12c(c3c(c4c5c(c(c(cc5n3)F)C)CC[C@@H]4N)C2)cc2c(c1=O)CO<br />C(=O)[C@]2(O)CC
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Toposisomerase-1 | Target Info | Inhibitor | [526228] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | DNA replication | ||||
Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.